Monte Rosa Therapeutics Inc Capital Reinvestment Ratio
Monte Rosa Therapeutics Inc capital reinvestment ratio. Monte Rosa Therapeutics Inc (GLUE) has a Capital Reinvestment Ratio of 0.01x as of September 2025, meaning it reinvests 0% of its operating cash flow ($100.43 Million) in capital expenditures ($651.00K). Check Monte Rosa Therapeutics Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Monte Rosa Therapeutics Inc (2024–2024)
Capital reinvestment ratio of Monte Rosa Therapeutics Inc from 2024 to 2024. This chart tracks Monte Rosa Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore GLUE net assets growth trend to track the company's year-over-year net asset growth rate.
Monte Rosa Therapeutics Inc Capital Reinvestment Ratio by Year (2024–2024)
Monte Rosa Therapeutics Inc capital reinvestment ratio by year from 2024 to 2024. For the full cash flow conversion analysis, see Monte Rosa Therapeutics Inc cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.09x | $42.00 Million | $3.99 Million | — |